← All trials
NCT04322253
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 24, 2017
- Primary completion
- Aug 22, 2018
- Completion date
- Dec 17, 2018
- First posted
- Mar 26, 2020
- Last posted
- Mar 26, 2020
- Enrollment
- 22
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- BayerLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.